Wave Life Sciences Ltd. (WVE) › Shareholders' EquityWave Life Sciences Ltd. (WVE) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: -$4.58M2013: -$7.76M2014: $2.03M2015: $153.49M2016: $134.60M2017: $139.61M2018: $73.35M2019: $63.73M2020: $82.78M2021: $32.50M2022: -$45.09M2023: $39.63M2024: $209.51M2025: $518.36M$518.36M2012Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$518.36M+147.4%2024$209.51M+428.7%2023$39.63M+187.9%2022-$45.09M-238.8%2021$32.50M-60.7%2020$82.78M+29.9%2019$63.73M-13.1%2018$73.35M-47.5%2017$139.61M+3.7%2016$134.60M-12.3%2015$153.49M+7472.3%2014$2.03M+126.1%2013-$7.76M-69.5%2012-$4.58M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share